| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hematoma, Subdural | D006408 | 3 associated lipids |
| Hemophilia A | D006467 | 10 associated lipids |
| Hepatitis C | D006526 | 7 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Hip Dislocation | D006617 | 1 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Histiocytosis, Langerhans-Cell | D006646 | 1 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Guzel S et al. | Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. | 2013 | Diab Vasc Dis Res | pmid:22496403 |
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Uehara H et al. | Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. | 2013 | Int. J. Oncol. | pmid:23708710 |
| Luo J et al. | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 | Biomed Res Int | pmid:23710436 |
| Zhu Y et al. | Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. | 2013 | J. Cell. Physiol. | pmid:22674471 |
| Neunaber C et al. | Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. | 2013 | Injury | pmid:23773407 |
| Koide M et al. | Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. | 2013 | Endocrinology | pmid:23291450 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Bauer S et al. | Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. | 2013 | Epilepsy Res. | pmid:23916144 |
| Nile CJ et al. | Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. | 2013 | J. Clin. Periodontol. | pmid:23919740 |
| Kim HR et al. | The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. | 2013 | Nephron Clin Pract | pmid:23921088 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Steensma MR et al. | Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. | 2013 | PLoS ONE | pmid:23922683 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Yu J et al. | Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. | 2013 | Biol Trace Elem Res | pmid:23456427 |
| Lau CP et al. | Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. | 2013 | Connect. Tissue Res. | pmid:24060052 |
| Corrado A et al. | RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. | 2013 | J. Rheumatol. | pmid:23457386 |
| Koluman BU et al. | Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. | 2013 | Clin. Nephrol. | pmid:23458176 |
| Wang J et al. | Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. | 2013 | Med. Hypotheses | pmid:24074896 |
| Kuo PL et al. | MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. | 2013 | Biochim. Biophys. Acta | pmid:23458685 |
| Li F et al. | Effect of parathyroid hormone on experimental tooth movement in rats. | 2013 | Am J Orthod Dentofacial Orthop | pmid:24075660 |
| Asanuma YF et al. | Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. | 2013 | Mod Rheumatol | pmid:22584471 |
| Sato K et al. | RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. | 2013 | Am. J. Pathol. | pmid:23499553 |
| Pneumaticos SG et al. | Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. | 2013 | Expert Opin. Ther. Targets | pmid:24024908 |
| Sooampon S et al. | Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. | 2013 | J. Periodont. Res. | pmid:22587561 |
| Matuszewski Å et al. | Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. | 2013 | Int Orthop | pmid:23503639 |
| Galli C et al. | GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. | 2013 | Clin Oral Implants Res | pmid:22626030 |
| Albers J et al. | Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. | 2013 | J. Cell Biol. | pmid:23401003 |
| Wang Q et al. | The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. | 2013 | Int. Immunopharmacol. | pmid:23856613 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Zappitelli T et al. | The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. | 2013 | J. Bone Miner. Res. | pmid:23606335 |
| Kao SY et al. | Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. | 2013 | Neurobiol. Dis. | pmid:23607938 |
| Wu M et al. | Vascular calcification: an update on mechanisms and challenges in treatment. | 2013 | Calcif. Tissue Int. | pmid:23456027 |
| Venojärvi M et al. | 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. | 2013 | Food Chem. Toxicol. | pmid:23623841 |
| Kitamura K et al. | Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. | 2013 | Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. | pmid:23632157 |
| Zhong Z et al. | Comparison of the biological response of osteoblasts after tension and compression. | 2013 | Eur J Orthod | pmid:21402736 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Gao L et al. | Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. | 2013 | J. Immunol. | pmid:23241890 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Kim SJ et al. | Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. | 2013 | Arch. Oral Biol. | pmid:23219295 |
| Kanzaki H et al. | Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. | 2013 | Exp. Mol. Pathol. | pmid:23219833 |
| Wang H et al. | Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. | 2013 | Gene Ther. | pmid:22318091 |
| Hussien YM et al. | Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. | 2013 | Mol. Biol. Rep. | pmid:23271131 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Hartwich JE et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. | 2013 | J. Pediatr. Surg. | pmid:23331792 |
| Naidu VG et al. | RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. | 2013 | Chem. Biol. Interact. | pmid:23333834 |
| Zhang Q et al. | Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. | 2013 | ScientificWorldJournal | pmid:24222748 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Luo ZR et al. | [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. | 2013 | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | pmid:24225213 |
| Zhang F et al. | Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. | 2013 | Med. Oncol. | pmid:23335067 |
| Tisato V et al. | GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. | 2013 | Mediators Inflamm. | pmid:24327798 |
| Su SJ et al. | Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. | 2013 | Int J Food Sci Nutr | pmid:23301724 |
| Aoki A et al. | Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. | 2013 | Cardiovasc Diabetol | pmid:23302066 |
| Pathan E et al. | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. | 2013 | Ann. Rheum. Dis. | pmid:22984171 |
| Guerra-Menéndez L et al. | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | 2013 | J Transl Med | pmid:24161214 |
| Montagnana M et al. | The role of osteoprotegerin in cardiovascular disease. | 2013 | Ann. Med. | pmid:23110639 |
| Romagnoli C et al. | Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. | 2013 | FEBS J. | pmid:23176170 |
| Revu S et al. | Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. | 2013 | Arthritis Res. Ther. | pmid:24295447 |
| Kadkhodazadeh M et al. | Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. | 2013 | Arch. Oral Biol. | pmid:23177932 |
| Gutiérrez-Rojas I et al. | Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. | 2013 | Mol. Cell. Endocrinol. | pmid:23178165 |
| Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
| Bolzoni M et al. | Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. | 2013 | Exp. Hematol. | pmid:23178378 |
| Lee MH et al. | The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:22717323 |
| Mercatali L et al. | RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. | 2013 | Int J Mol Sci | pmid:23702841 |
| Braun T et al. | Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. | 2013 | J. Bone Miner. Res. | pmid:23169443 |
| Pereira AC et al. | Histomorphometrical and molecular evaluation of endosseous dental implants sites in humans: correlation with clinical and radiographic aspects. | 2013 | Clin Oral Implants Res | pmid:22092653 |
| Tousoulis D et al. | Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. | 2013 | Int. J. Cardiol. | pmid:22640692 |
| Rivadeneira F | Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. | 2013 | Endocrine | pmid:23001603 |
| Scott JP et al. | Effect of recovery duration between two bouts of running on bone metabolism. | 2013 | Med Sci Sports Exerc | pmid:23034642 |
| Nanjundaiah SM et al. | Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. | 2013 Jan-Mar | Int J Immunopathol Pharmacol | pmid:23527707 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Glintborg D et al. | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23211475 |
| Zamora PO et al. | Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. | 2013 Mar-Apr | Int. J. Toxicol. | pmid:23422080 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Liu S et al. | Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. | 2013 Oct-Dec | Hormones (Athens) | pmid:24457406 |
| Chiang PH et al. | Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. | 2013 Oct-Dec | J Cancer Res Ther | pmid:24518712 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Sagar DR et al. | Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. | 2014 | Ann. Rheum. Dis. | pmid:23723320 |
| Liu M et al. | Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. | 2014 | Stem Cells Dev. | pmid:24007307 |
| Miller RE et al. | RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. | 2014 | J Thorac Oncol | pmid:24496001 |
| Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
| MacMillan AK et al. | Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. | 2014 | Int J Nanomedicine | pmid:25506216 |
| Akiyama T et al. | Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. | 2014 | J. Biol. Chem. | pmid:24755218 |
| Köttstorfer J et al. | Are OPG and RANKL involved in human fracture healing? | 2014 | J. Orthop. Res. | pmid:25212894 |
| Esteghamati A et al. | Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. | 2014 | Arch Iran Med | pmid:25204474 |
| Kuroyanagi G et al. | Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. | 2014 | Arch. Biochem. Biophys. | pmid:24333336 |
| Jung Koo H et al. | Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. | 2014 | J Ethnopharmacol | pmid:24333364 |
| Bosman MC et al. | Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. | 2014 | J. Biol. Chem. | pmid:24280212 |
| Araújo AA et al. | Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. | 2014 | PLoS ONE | pmid:24819928 |
| Cianciolo G et al. | Importance of vascular calcification in kidney transplant recipients. | 2014 | Am. J. Nephrol. | pmid:24819032 |
| Sänger N et al. | OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. | 2014 | Mol Oncol | pmid:24785095 |
| Hidayat R et al. | Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. | 2014 | Acta Med Indones | pmid:24760805 |
| Shao X et al. | Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. | 2014 | J Diabetes Res | pmid:24812633 |
| Navratilova Z et al. | Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. | 2014 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:22660233 |